The effect of a levonorgestrel-releasing intrauterine device on female sexual function

References

• Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M, et al. 2000. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG: An International Journal of Obstetrics and Gynaecology 107:335–339.
   PubMed Web of Science ®Google Scholar
• Banaei M, Alidost F, Ghasemi E, Dashti S. 2020. A comparison of sexual function in primiparous and multiparous women. Journal of Obstetrics and Gynaecology 40:411–418.
   PubMed Web of Science ®Google Scholar
• Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, et al. 2000. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. Journal of Urology 163:888–893.
   PubMed Web of Science ®Google Scholar
• Bastianelli C, Farris M, Benagiano G. 2011. Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center. Contraception 84:402–408.
   PubMed Web of Science ®Google Scholar
• Blumenthal PD, Trussell J, Singh RH, Guo A, Borenstein J, Dubois RW, et al. 2006. Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception. Contraception 74:249–258.
   PubMed Web of Science ®Google Scholar
• Both S, Lew-Starowicz M, Luria M, Sartorius G, Maseroli E, Tripodi F, et al. 2019. Hormonal contraception and female sexuality: position statements from the European Society of Sexual Medicine (ESSM). The Journal of Sexual Medicine 16:1681–1695.
   PubMed Web of Science ®Google Scholar
• Brache V, Faundes A, Alvarez F, Cochon L. 2002. Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception 65:63–74.
   PubMed Web of Science ®Google Scholar
• Casado-Espada NM, de Alarcón R, de la Iglesia-Larrad JI, Bote-Bonaechea B, Montejo ÁL. 2019. Hormonal contraceptives, female sexual dysfunction, and managing strategies: a review. Journal of Clinical Medicine 8:908.
   PubMed Web of Science ®Google Scholar
• Casey PM, Maclaughlin KL, Faubion SS. 2017. Impact of contraception on female sexual function. Journal of Women’s Health 26:207–213.
   PubMed Web of Science ®Google Scholar
• Cim N, Soysal S, Sayan S, Yildizhan B, Karaman E, Cetin O, et al. 2018. Two years follow-up of patients with abnormal uterine bleeding after insertion of the levonorgestrel-releasing intrauterine system. Gynecologic and Obstetric Investigation 83:569–575.
   PubMed Web of Science ®Google Scholar
• Daud S, Ewies AAA. 2008. Levonorgestrel-releasing intrauterine system: why do some women dislike it? Gynecological Endocrinology 24:686–690.
   PubMed Web of Science ®Google Scholar
• Davison SL, Davis SR. 2003. Androgens in women. The Journal of Steroid Biochemistry and Molecular Biology 85:363–366.
   PubMed Web of Science ®Google Scholar
• Enzlin P, Weyers S, Janssens D, Poppe W, Eelen C, Pazmany E, et al. 2012. Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices. The Journal of Sexual Medicine 9:1065–1073.
   PubMed Web of Science ®Google Scholar
• Ferreira J, Carreiro A, Fernandes A, Bahamondes L. 2019. Sexual function and quality of life in a cohort of Brazilian users of two kind of intrauterine contraceptives’. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics 41:236–241.
   Google Scholar
• Gemzell-Danielsson K, Inki P, Boubli L, O’Flynn M, Kunz M, Heikinheimo O, et al. 2010. Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS) – a multicentre prospective study. Human Reproduction 25:354–359.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Inki P, Heikinheimo O. 2013. Safety and efficacy of the levonorgestrel-releasing intrauterine system: recent insights. Expert Review of Obstetricsand Gynecology 8:235–247.
   Google Scholar
• Gorgen H, Api M, Akça A, Cetin A. 2009. Use of the levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Archives of Gynecology and Obstetrics 279:835–840.
   PubMed Web of Science ®Google Scholar
• Guida M, Cibarelli F, Troisi J, Gallo A, Palumbo AR, Di Spiezio Sardo A, et al. 2014. Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration. Archives of Gynecology and Obstetrics 290:1239–1247.
   PubMed Web of Science ®Google Scholar
• Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J, et al. 2013. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. New England Journal of Medicine 368:128–137.
   PubMed Web of Science ®Google Scholar
• Halmesmäki K, Hurskainen R, Teperi J, Grenman S, Kivelä A, Kujansuu E, et al. 2007. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology 114:563–568.
   PubMed Web of Science ®Google Scholar
• Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivelä A, et al. 2004. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 291:1456–1463.
   PubMed Web of Science ®Google Scholar
• Kuehn R, Casaubon J, Raker C, Edmonson D, Stuckey A, Gass J, et al. 2019. Sexual dysfunction in survivorship; the impact of menopause and endocrine therapy. Annals of Surgical Oncology 26:3159–3165.
   PubMed Web of Science ®Google Scholar
• Maseroli E, Scavello I, Vignozzi L. 2018a. Cardiometabolic risk and female sexuality—part I. Risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes. Sexual Medicine Reviews 6:508–524.
   PubMed Web of Science ®Google Scholar
• Maseroli E, Scavello I, Vignozzi L. 2018b. Cardiometabolic risk and female sexuality—part II. Understanding (and overcoming) gender differences: the key role of an adequate methodological approach. Sexual Medicine Reviews 6:525–534.
   PubMed Web of Science ®Google Scholar
• McCarthy L. 2006. Levonorgestrel-releasing intrauterine system (Mirena) for contraception. American Family Physician 73:1799–1802.
   Web of Science ®Google Scholar
• Meirik O. 2003. Implantable contraceptives for women. Human Reproduction Update 9:49–59.
   PubMed Web of Science ®Google Scholar
• Neri M, Piras B, Paoletti AM, Vallerino V, Corda V, Ronchetti C, et al. 2018. Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women. Gynecological Endocrinology 34:532–535.
   PubMed Web of Science ®Google Scholar
• Palm C, Essén B, Johnsdotter S. 2019. Sexual health counselling targeting girls and young women with female genital cutting in Sweden: mind–body dualism affecting social and health care professionals’ perspectives. Sexual and Reproductive Health Matters 27:192–202.
   Web of Science ®Google Scholar
• Philip S, Taylor AH, Konje JC, Habiba M. 2019. The levonorgestrel-releasing intrauterine device induces endometrial decidualisation in women on tamoxifen. Journal of Obstetrics and Gynaecology 39:1117–1122.
   PubMed Web of Science ®Google Scholar
• Phillips V. 2003. The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. Journal of Clinical Pathology 56:305–307.
   PubMed Web of Science ®Google Scholar
• Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. 2000. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex and Marital Therapy 26:191–205.
   PubMed Web of Science ®Google Scholar
• Sakinci M, Ercan CM, Olgan S, Coksuer H, Karasahin KE, Kuru O, et al. 2016. Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes. Taiwanese Journal of Obstetrics and Gynecology 55:30–34.
   PubMed Web of Science ®Google Scholar
• Shulman LP, Nelson AL, Darney PD. 2004. Recent developments in hormone delivery systems. American Journal of Obstetrics and Gynecology 190:S39–S48.
   PubMed Web of Science ®Google Scholar
• Simón E, Tejerizo Á, Muñoz JL, Álvarez C, Marqueta L, Jiménez JS, et al. 2017. Conservative management in ureteric hydronephrosis due to deep endometriosis: could the levonorgestrel-intrauterine device be an option? Journal of Obstetrics and Gynaecology 37:639–644.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Inki P. 2005. The levonorgestrel intrauterine system: long-term contraception and therapeutic effects. Women’s Health 1:171–182.
   PubMedGoogle Scholar
• Skrzypulec V, Drosdzol A. 2008. Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system Mirena. Collegium Antropologicum 32:1059–1068.
   PubMedGoogle Scholar
• Yun HJ, Cho HH. 2018. The characteristics of hypoactive sexual desire disorder in Korean women who visited a community-based gynaecology hospital for sexual dysfunction. Journal of Obstetrics and Gynaecology 38:663–667.
   PubMed Web of Science ®Google Scholar
• Zalel Y, Gamzu R, Shulman A, Achiron R, Schiff G, Lidor A, et al. 2003. The progestative effect of the levonorgestrel-releasing intrauterine system – when does it manifest? Contraception 67:473–476.
   PubMed Web of Science ®Google Scholar